Table 4 Logistic regression analysis of TyG-BMI and hypertension

From: Triglyceride glucose-body mass index as a mediator of hypertension risk in obstructive sleep apnoea syndrome: a mediation analysis study

TyG-BMI

Hypertension (yes/no)

OR (95%CI)

OR (95%CI)

OR (95%CI)

  

Model 1

P

Model 2

P

Model 3

P

Q1

118/92

Reference

Reference

Reference

Q2

136/74

1.433 (0.967-2.123)

0.073

1.606 (1.057-2.442)

0.027

1.576 (1.015-2.445)

0.043

Q3

154/56

2.144 (1.423-3.230)

< 0.001

2.673 (1.712-4.172)

< 0.001

2.457 (1.527-3.954)

< 0.001

Q4

165/45

2.859 (1.864-4.385)

< 0.001

4.225 (2.603-6.859)

< 0.001

3.407 (2.001-5.802)

<0.001

  1. Model 1: crude model;
  2. Model 2: Adjusted for sex, age, smoking history, alcohol consumption history, white blood cell, haemoglobin, platelet, neutrophil, lymphocyte and monocyte counts;
  3. Model 3: Adjusted for sex, age, smoking, alcohol, white blood cells, haemoglobin, platelets, neutrophils, lymphocytes, monocytes, alanine aminotransferase, aspartate aminotransferase, creatinine, uric acid, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, sleep efficiency, diabetes, and coronary heart disease